Author Index

Search or browse for an author across our entire electronic archive

Search results for: G
Results 131 - 140 of 1441 shown below

  • Gambardella, A

    P Comella, A Farris, V Lorusso, S Palmeri, L Maiorino, L De Lucia, F Buzzi, S Mancarella, F De Vita and A Gambardella

    Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinoma

    doi:10.1038/sj.bjc.6601214

  • Gambarota, G

    G Gambarota, W Leenders, C Maass, P Wesseling, B van der Kogel, O van Tellingen and A Heerschap

    Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI

    advance online publication, 2008-05-27 00:00:00.000;

    doi:10.1038/sj.bjc.6604389

  • Gambi, A

    O Nanni, A Volpi, G L Frassineti, F De Paola, A M Granato, A Dubini, W Zoli, E Scarpi, D Turci, G Oliverio, A Gambi and D Amadori

    Role of biological markers in the clinical outcome of colon cancer

    doi:10.1038/sj.bjc.6600569

  • Gambini, C

    I Airoldi, S Lualdi, S Bruno, L Raffaghello, M Occhino, C Gambini, V Pistoia and M V Corrias

    Expression of costimulatory molecules in human neuroblastoma. Evidence that CD40+ neuroblastoma cells undergo apoptosis following interaction with CD40L

    doi:10.1038/sj.bjc.6600951

  • A Iolascon, L Giordani, A Borriello, R Carbone, A Izzo, G P Tonini, C Gambini and F Della Ragione

    Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomas

    doi:10.1054/bjoc.1999.1058

  • Gamble, S C

    S C Gamble, H Wolff and J E Arrand

    Syrian hamster dermal cell immortalization is not enhanced by power line frequency electromagnetic field exposure

    doi:10.1038/sj.bjc.6690704

  • Gambotti, L

    V Martinez, E Caumes, L Gambotti, H Ittah, J-P Morini, J Deleuze, I Gorin, C Katlama, F Bricaire and N Dupin

    Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy

    advance online publication, 2006-03-28 00:00:00.000;

    doi:10.1038/sj.bjc.6603056

  • Y M Kirova, Y De Rycke, L Gambotti, J-Y Pierga, B Asselain and A Fourquet

    Second malignancies after breast cancer: the impact of different treatment modalities

    advance online publication, 2008-02-12 00:00:00.000;

    doi:10.1038/sj.bjc.6604241

  • Game, P A

    P Coyle, G Mathew, P A Game, J C Myers, J C Philcox, A M Rofe and G G Jamieson

    Metallothionein in human oesophagus, Barrett's epithelium and adenocarcinoma

    doi:10.1038/sj.bjc.6600473

  • Gamelin, E

    A Lortholary, T Delozier, A Monnier, H Bourgeois, P Bougnoux, N Tubiana-Mathieu, J Ch Riffaud, D Besson, V Lotz and E Gamelin

    Phase II multicentre study of docetaxel plus 5-fluorouracil in patients with anthracycline-pretreated metastatic breast cancer

    doi:10.1038/sj.bjc.6600989

  • E Rouits, V Charasson, A Pétain, M Boisdron-Celle, J-P Delord, M Fonck, A Laurand, A-L Poirier, A Morel, E Chatelut, J Robert and E Gamelin

    Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients

    advance online publication, 2008-09-16 00:00:00.000;

    doi:10.1038/sj.bjc.6604673

  • M A Bensmaïne, M Marty, A de Gramont, S Brienza, F Lévi, M Ducreux, E François, E Gamelin, H Bleiberg and E Cvitkovic

    Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) plusminus folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients

    doi:10.1054/bjoc.2001.1953

  • Gammell, P

    S A Glynn, P Gammell, M Heenan, R O'Connor, Y Liang, J Keenan and M Clynes

    A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin

    advance online publication, 2004-10-26 00:00:00.000;

    doi:10.1038/sj.bjc.6602221

  • Gammon, M D

    M D Althuis, D R Brogan, R J Coates, J R Daling, M D Gammon, K E Malone, J B Schoenberg and L A Brinton

    Hormonal content and potency of oral contraceptives and breast cancer risk among young women

    doi:10.1038/sj.bjc.6600691

  • M D Gammon, B N Fink, S E Steck and M S Wolff

    Soy intake and breast cancer: elucidation of an unanswered question

    advance online publication, 2008-01-08 00:00:00.000;

    doi:10.1038/sj.bjc.6604182

  • R J Coates, R J Uhler, H I Hall, N Potischman, L A Brinton, R Ballard-Barbash, M D Gammon, D R Brogan, J R Daling, K E Malone, J B Schoenberg and C A Swanson

    Risk of breast cancer in young women in relation to body size and weight gain in adolescence and early adulthood

    doi:10.1038/sj.bjc.6690667

  • L A Brinton, M D Gammon, R J Coates and R N Hoover

    Tubal ligation and risk of breast cancer

    doi:10.1054/bjoc.1999.1182

  • J A Britton, C Westhoff, G R Howe and M D Gammon

    Lactose and benign ovarian tumours in a case-control study

    doi:10.1054/bjoc.2000.1476